nodes	percent_of_prediction	percent_of_DWPC	metapath
Idarubicin—Doxorubicin—lung cancer	0.248	1	CrCtD
Idarubicin—Topoisomerase Inhibitors—Teniposide—lung cancer	0.0926	0.23	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Topotecan—lung cancer	0.0825	0.205	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Irinotecan—lung cancer	0.0702	0.174	CiPCiCtD
Idarubicin—Anthracyclines—Doxorubicin—lung cancer	0.0671	0.167	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Etoposide—lung cancer	0.0551	0.137	CiPCiCtD
Idarubicin—Epirubicin—Doxorubicin—lung cancer	0.0522	0.333	CrCrCtD
Idarubicin—Valrubicin—Doxorubicin—lung cancer	0.0522	0.333	CrCrCtD
Idarubicin—Daunorubicin—Doxorubicin—lung cancer	0.0522	0.333	CrCrCtD
Idarubicin—Topoisomerase Inhibitors—Doxorubicin—lung cancer	0.0351	0.0871	CiPCiCtD
Idarubicin—TOP2A—Teniposide—lung cancer	0.031	0.235	CbGbCtD
Idarubicin—TOP2A—Etoposide—lung cancer	0.0137	0.104	CbGbCtD
Idarubicin—ABCC1—Paclitaxel—lung cancer	0.00958	0.0728	CbGbCtD
Idarubicin—ABCC1—Irinotecan—lung cancer	0.00945	0.0718	CbGbCtD
Idarubicin—TOP2A—Doxorubicin—lung cancer	0.00931	0.0708	CbGbCtD
Idarubicin—ABCC1—Vinblastine—lung cancer	0.0084	0.0639	CbGbCtD
Idarubicin—ABCC1—Etoposide—lung cancer	0.00757	0.0575	CbGbCtD
Idarubicin—ABCC1—Docetaxel—lung cancer	0.00693	0.0526	CbGbCtD
Idarubicin—ABCC1—Doxorubicin—lung cancer	0.00516	0.0392	CbGbCtD
Idarubicin—ABCC1—Methotrexate—lung cancer	0.005	0.038	CbGbCtD
Idarubicin—CYP2C9—Gefitinib—lung cancer	0.0044	0.0334	CbGbCtD
Idarubicin—CYP2C9—Teniposide—lung cancer	0.00427	0.0324	CbGbCtD
Idarubicin—CYP2D6—Gefitinib—lung cancer	0.00402	0.0306	CbGbCtD
Idarubicin—CYP2D6—Vinorelbine—lung cancer	0.0031	0.0236	CbGbCtD
Idarubicin—CYP2C9—Paclitaxel—lung cancer	0.00238	0.0181	CbGbCtD
Idarubicin—CYP2D6—Erlotinib—lung cancer	0.00238	0.0181	CbGbCtD
Idarubicin—CYP2C9—Cisplatin—lung cancer	0.00192	0.0146	CbGbCtD
Idarubicin—CYP2D6—Vinblastine—lung cancer	0.00191	0.0145	CbGbCtD
Idarubicin—CYP2D6—Doxorubicin—lung cancer	0.00117	0.00892	CbGbCtD
Idarubicin—Doxorubicin—NQO1—lung cancer	0.000213	0.253	CrCbGaD
Idarubicin—Doxorubicin—ABCC3—lung cancer	0.00021	0.249	CrCbGaD
Idarubicin—Daunorubicin—ABCG2—lung cancer	0.000125	0.149	CrCbGaD
Idarubicin—TOP2A—Docetaxel—Paclitaxel—lung cancer	0.000102	0.0985	CbGdCrCtD
Idarubicin—Doxorubicin—ABCG2—lung cancer	0.000102	0.121	CrCbGaD
Idarubicin—Daunorubicin—CYP1A1—lung cancer	9.82e-05	0.117	CrCbGaD
Idarubicin—TOP2A—Irinotecan—Topotecan—lung cancer	8.76e-05	0.0843	CbGdCrCtD
Idarubicin—TOP2A—Erlotinib—Gefitinib—lung cancer	7.64e-05	0.0736	CbGdCrCtD
Idarubicin—TOP2A—Topotecan—Irinotecan—lung cancer	7.28e-05	0.0701	CbGdCrCtD
Idarubicin—TOP2A—Etoposide—Teniposide—lung cancer	7.23e-05	0.0696	CbGdCrCtD
Idarubicin—TOP2A—Vindesine—Vinorelbine—lung cancer	6.51e-05	0.0626	CbGdCrCtD
Idarubicin—TOP2A—Podofilox—Teniposide—lung cancer	5.51e-05	0.0531	CbGdCrCtD
Idarubicin—Daunorubicin—ABCB1—lung cancer	5.22e-05	0.062	CrCbGaD
Idarubicin—TOP2A—Vindesine—Vinblastine—lung cancer	5.2e-05	0.0501	CbGdCrCtD
Idarubicin—TOP2A—Methotrexate—Pemetrexed—lung cancer	5.19e-05	0.05	CbGdCrCtD
Idarubicin—TOP2A—Paclitaxel—Docetaxel—lung cancer	5.11e-05	0.0492	CbGdCrCtD
Idarubicin—TOP2A—Afatinib—Gefitinib—lung cancer	5e-05	0.0481	CbGdCrCtD
Idarubicin—TOP2A—Gefitinib—Erlotinib—lung cancer	4.9e-05	0.0472	CbGdCrCtD
Idarubicin—Doxorubicin—ABCB1—lung cancer	4.24e-05	0.0503	CrCbGaD
Idarubicin—TOP2A—Vincristine—Vinorelbine—lung cancer	3.51e-05	0.0338	CbGdCrCtD
Idarubicin—TOP2A—Vinorelbine—Vinblastine—lung cancer	3.28e-05	0.0316	CbGdCrCtD
Idarubicin—TOP2A—Teniposide—Etoposide—lung cancer	3.28e-05	0.0316	CbGdCrCtD
Idarubicin—TOP2A—Podofilox—Etoposide—lung cancer	3.28e-05	0.0316	CbGdCrCtD
Idarubicin—TOP2A—Vinblastine—Vinorelbine—lung cancer	2.82e-05	0.0272	CbGdCrCtD
Idarubicin—TOP2A—Vincristine—Vinblastine—lung cancer	2.81e-05	0.027	CbGdCrCtD
Idarubicin—Hypersensitivity—Vinblastine—lung cancer	2.44e-05	0.000497	CcSEcCtD
Idarubicin—Acute coronary syndrome—Docetaxel—lung cancer	2.42e-05	0.000493	CcSEcCtD
Idarubicin—Leukopenia—Gemcitabine—lung cancer	2.42e-05	0.000493	CcSEcCtD
Idarubicin—Flushing—Paclitaxel—lung cancer	2.42e-05	0.000492	CcSEcCtD
Idarubicin—Myocardial infarction—Docetaxel—lung cancer	2.41e-05	0.000491	CcSEcCtD
Idarubicin—Angiopathy—Etoposide—lung cancer	2.41e-05	0.000491	CcSEcCtD
Idarubicin—Immune system disorder—Etoposide—lung cancer	2.4e-05	0.000488	CcSEcCtD
Idarubicin—Stomatitis—Docetaxel—lung cancer	2.4e-05	0.000488	CcSEcCtD
Idarubicin—Decreased appetite—Vinorelbine—lung cancer	2.39e-05	0.000487	CcSEcCtD
Idarubicin—Chills—Etoposide—lung cancer	2.38e-05	0.000485	CcSEcCtD
Idarubicin—Sepsis—Doxorubicin—lung cancer	2.38e-05	0.000485	CcSEcCtD
Idarubicin—Hypersensitivity—Topotecan—lung cancer	2.37e-05	0.000482	CcSEcCtD
Idarubicin—Angiopathy—Paclitaxel—lung cancer	2.36e-05	0.000481	CcSEcCtD
Idarubicin—Immune system disorder—Paclitaxel—lung cancer	2.35e-05	0.000479	CcSEcCtD
Idarubicin—Alopecia—Etoposide—lung cancer	2.35e-05	0.000478	CcSEcCtD
Idarubicin—Chills—Paclitaxel—lung cancer	2.34e-05	0.000476	CcSEcCtD
Idarubicin—Anaemia—Cisplatin—lung cancer	2.33e-05	0.000475	CcSEcCtD
Idarubicin—Arrhythmia—Paclitaxel—lung cancer	2.33e-05	0.000474	CcSEcCtD
Idarubicin—Phlebitis—Doxorubicin—lung cancer	2.31e-05	0.000471	CcSEcCtD
Idarubicin—Chest pain—Gemcitabine—lung cancer	2.31e-05	0.000469	CcSEcCtD
Idarubicin—Alopecia—Paclitaxel—lung cancer	2.3e-05	0.000469	CcSEcCtD
Idarubicin—Thrombophlebitis—Doxorubicin—lung cancer	2.3e-05	0.000468	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	2.29e-05	0.000466	CcSEcCtD
Idarubicin—Hepatic function abnormal—Doxorubicin—lung cancer	2.28e-05	0.000464	CcSEcCtD
Idarubicin—Anaphylactic shock—Irinotecan—lung cancer	2.27e-05	0.000462	CcSEcCtD
Idarubicin—Malnutrition—Paclitaxel—lung cancer	2.27e-05	0.000462	CcSEcCtD
Idarubicin—Diarrhoea—Vinblastine—lung cancer	2.26e-05	0.000461	CcSEcCtD
Idarubicin—Leukopenia—Cisplatin—lung cancer	2.26e-05	0.00046	CcSEcCtD
Idarubicin—Infection—Irinotecan—lung cancer	2.25e-05	0.000459	CcSEcCtD
Idarubicin—Gastrointestinal pain—Vinorelbine—lung cancer	2.25e-05	0.000458	CcSEcCtD
Idarubicin—Shock—Irinotecan—lung cancer	2.23e-05	0.000454	CcSEcCtD
Idarubicin—Thrombocytopenia—Irinotecan—lung cancer	2.22e-05	0.000452	CcSEcCtD
Idarubicin—Haemoglobin—Docetaxel—lung cancer	2.22e-05	0.000452	CcSEcCtD
Idarubicin—Anaphylactic shock—Gemcitabine—lung cancer	2.21e-05	0.00045	CcSEcCtD
Idarubicin—Haemorrhage—Docetaxel—lung cancer	2.21e-05	0.000449	CcSEcCtD
Idarubicin—Diarrhoea—Topotecan—lung cancer	2.2e-05	0.000448	CcSEcCtD
Idarubicin—Cardiac failure congestive—Doxorubicin—lung cancer	2.2e-05	0.000447	CcSEcCtD
Idarubicin—Infection—Gemcitabine—lung cancer	2.2e-05	0.000447	CcSEcCtD
Idarubicin—Convulsion—Cisplatin—lung cancer	2.19e-05	0.000445	CcSEcCtD
Idarubicin—Urticaria—Vinorelbine—lung cancer	2.19e-05	0.000445	CcSEcCtD
Idarubicin—Urinary tract disorder—Docetaxel—lung cancer	2.18e-05	0.000444	CcSEcCtD
Idarubicin—Diarrhoea—Erlotinib—lung cancer	2.18e-05	0.000443	CcSEcCtD
Idarubicin—Abdominal pain—Vinorelbine—lung cancer	2.17e-05	0.000443	CcSEcCtD
Idarubicin—Body temperature increased—Vinorelbine—lung cancer	2.17e-05	0.000443	CcSEcCtD
Idarubicin—Urethral disorder—Docetaxel—lung cancer	2.16e-05	0.000441	CcSEcCtD
Idarubicin—Thrombocytopenia—Gemcitabine—lung cancer	2.16e-05	0.000441	CcSEcCtD
Idarubicin—Anorexia—Irinotecan—lung cancer	2.16e-05	0.00044	CcSEcCtD
Idarubicin—Skin disorder—Gemcitabine—lung cancer	2.15e-05	0.000437	CcSEcCtD
Idarubicin—Anaemia—Etoposide—lung cancer	2.14e-05	0.000435	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	2.13e-05	0.000434	CcSEcCtD
Idarubicin—Hot flush—Doxorubicin—lung cancer	2.13e-05	0.000433	CcSEcCtD
Idarubicin—Menopausal symptoms—Doxorubicin—lung cancer	2.11e-05	0.00043	CcSEcCtD
Idarubicin—Anorexia—Gemcitabine—lung cancer	2.11e-05	0.000429	CcSEcCtD
Idarubicin—Vomiting—Vinblastine—lung cancer	2.1e-05	0.000428	CcSEcCtD
Idarubicin—Anaemia—Paclitaxel—lung cancer	2.1e-05	0.000427	CcSEcCtD
Idarubicin—Headache—Vinblastine—lung cancer	2.07e-05	0.000422	CcSEcCtD
Idarubicin—Leukopenia—Etoposide—lung cancer	2.07e-05	0.000421	CcSEcCtD
Idarubicin—Anaphylactic shock—Cisplatin—lung cancer	2.06e-05	0.000419	CcSEcCtD
Idarubicin—Flushing—Docetaxel—lung cancer	2.05e-05	0.000417	CcSEcCtD
Idarubicin—Infection—Cisplatin—lung cancer	2.05e-05	0.000417	CcSEcCtD
Idarubicin—Vomiting—Topotecan—lung cancer	2.04e-05	0.000416	CcSEcCtD
Idarubicin—Leukopenia—Paclitaxel—lung cancer	2.03e-05	0.000413	CcSEcCtD
Idarubicin—Rash—Topotecan—lung cancer	2.03e-05	0.000413	CcSEcCtD
Idarubicin—Hypersensitivity—Vinorelbine—lung cancer	2.03e-05	0.000413	CcSEcCtD
Idarubicin—Dermatitis—Topotecan—lung cancer	2.03e-05	0.000412	CcSEcCtD
Idarubicin—Vomiting—Erlotinib—lung cancer	2.02e-05	0.000412	CcSEcCtD
Idarubicin—Thrombocytopenia—Cisplatin—lung cancer	2.02e-05	0.000411	CcSEcCtD
Idarubicin—Headache—Topotecan—lung cancer	2.01e-05	0.00041	CcSEcCtD
Idarubicin—Rash—Erlotinib—lung cancer	2.01e-05	0.000408	CcSEcCtD
Idarubicin—Dermatitis—Erlotinib—lung cancer	2e-05	0.000408	CcSEcCtD
Idarubicin—Convulsion—Etoposide—lung cancer	2e-05	0.000408	CcSEcCtD
Idarubicin—Angiopathy—Docetaxel—lung cancer	2e-05	0.000408	CcSEcCtD
Idarubicin—Skin disorder—Cisplatin—lung cancer	2e-05	0.000407	CcSEcCtD
Idarubicin—Immune system disorder—Docetaxel—lung cancer	1.99e-05	0.000406	CcSEcCtD
Idarubicin—Headache—Erlotinib—lung cancer	1.99e-05	0.000406	CcSEcCtD
Idarubicin—Chills—Docetaxel—lung cancer	1.98e-05	0.000403	CcSEcCtD
Idarubicin—Decreased appetite—Irinotecan—lung cancer	1.97e-05	0.000402	CcSEcCtD
Idarubicin—Arrhythmia—Docetaxel—lung cancer	1.97e-05	0.000401	CcSEcCtD
Idarubicin—Chest pain—Etoposide—lung cancer	1.97e-05	0.000401	CcSEcCtD
Idarubicin—Nausea—Vinblastine—lung cancer	1.97e-05	0.0004	CcSEcCtD
Idarubicin—Convulsion—Paclitaxel—lung cancer	1.96e-05	0.0004	CcSEcCtD
Idarubicin—Anorexia—Cisplatin—lung cancer	1.96e-05	0.0004	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	1.96e-05	0.000398	CcSEcCtD
Idarubicin—Alopecia—Docetaxel—lung cancer	1.95e-05	0.000397	CcSEcCtD
Idarubicin—Chest pain—Paclitaxel—lung cancer	1.93e-05	0.000393	CcSEcCtD
Idarubicin—Malnutrition—Docetaxel—lung cancer	1.92e-05	0.000391	CcSEcCtD
Idarubicin—Decreased appetite—Gemcitabine—lung cancer	1.92e-05	0.000391	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	1.92e-05	0.00039	CcSEcCtD
Idarubicin—Nausea—Topotecan—lung cancer	1.91e-05	0.000389	CcSEcCtD
Idarubicin—Nausea—Erlotinib—lung cancer	1.89e-05	0.000385	CcSEcCtD
Idarubicin—Pancytopenia—Methotrexate—lung cancer	1.89e-05	0.000384	CcSEcCtD
Idarubicin—Anaphylactic shock—Etoposide—lung cancer	1.89e-05	0.000384	CcSEcCtD
Idarubicin—Diarrhoea—Vinorelbine—lung cancer	1.88e-05	0.000383	CcSEcCtD
Idarubicin—Infection—Etoposide—lung cancer	1.87e-05	0.000382	CcSEcCtD
Idarubicin—Neutropenia—Methotrexate—lung cancer	1.86e-05	0.000378	CcSEcCtD
Idarubicin—Gastrointestinal pain—Irinotecan—lung cancer	1.86e-05	0.000378	CcSEcCtD
Idarubicin—Dehydration—Doxorubicin—lung cancer	1.85e-05	0.000377	CcSEcCtD
Idarubicin—Anaphylactic shock—Paclitaxel—lung cancer	1.85e-05	0.000377	CcSEcCtD
Idarubicin—Thrombocytopenia—Etoposide—lung cancer	1.85e-05	0.000376	CcSEcCtD
Idarubicin—TOP2A—Cytarabine—Gemcitabine—lung cancer	1.84e-05	0.0178	CbGdCrCtD
Idarubicin—Infection—Paclitaxel—lung cancer	1.84e-05	0.000374	CcSEcCtD
Idarubicin—Skin disorder—Etoposide—lung cancer	1.83e-05	0.000373	CcSEcCtD
Idarubicin—Shock—Paclitaxel—lung cancer	1.82e-05	0.000371	CcSEcCtD
Idarubicin—Thrombocytopenia—Paclitaxel—lung cancer	1.81e-05	0.000369	CcSEcCtD
Idarubicin—Anorexia—Etoposide—lung cancer	1.8e-05	0.000366	CcSEcCtD
Idarubicin—Skin disorder—Paclitaxel—lung cancer	1.8e-05	0.000366	CcSEcCtD
Idarubicin—Body temperature increased—Irinotecan—lung cancer	1.79e-05	0.000365	CcSEcCtD
Idarubicin—Abdominal pain—Irinotecan—lung cancer	1.79e-05	0.000365	CcSEcCtD
Idarubicin—Decreased appetite—Cisplatin—lung cancer	1.79e-05	0.000365	CcSEcCtD
Idarubicin—Anaemia—Docetaxel—lung cancer	1.78e-05	0.000362	CcSEcCtD
Idarubicin—Anorexia—Paclitaxel—lung cancer	1.76e-05	0.000359	CcSEcCtD
Idarubicin—Vomiting—Vinorelbine—lung cancer	1.75e-05	0.000356	CcSEcCtD
Idarubicin—Body temperature increased—Gemcitabine—lung cancer	1.75e-05	0.000356	CcSEcCtD
Idarubicin—Rash—Vinorelbine—lung cancer	1.73e-05	0.000353	CcSEcCtD
Idarubicin—Dermatitis—Vinorelbine—lung cancer	1.73e-05	0.000353	CcSEcCtD
Idarubicin—Stomatitis—Methotrexate—lung cancer	1.73e-05	0.000352	CcSEcCtD
Idarubicin—Headache—Vinorelbine—lung cancer	1.72e-05	0.000351	CcSEcCtD
Idarubicin—Leukopenia—Docetaxel—lung cancer	1.72e-05	0.00035	CcSEcCtD
Idarubicin—Hypersensitivity—Irinotecan—lung cancer	1.67e-05	0.00034	CcSEcCtD
Idarubicin—Convulsion—Docetaxel—lung cancer	1.66e-05	0.000339	CcSEcCtD
Idarubicin—Decreased appetite—Etoposide—lung cancer	1.64e-05	0.000334	CcSEcCtD
Idarubicin—Chest pain—Docetaxel—lung cancer	1.64e-05	0.000333	CcSEcCtD
Idarubicin—Pancytopenia—Doxorubicin—lung cancer	1.63e-05	0.000333	CcSEcCtD
Idarubicin—Nausea—Vinorelbine—lung cancer	1.63e-05	0.000333	CcSEcCtD
Idarubicin—Body temperature increased—Cisplatin—lung cancer	1.63e-05	0.000332	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	1.62e-05	0.000331	CcSEcCtD
Idarubicin—Neutropenia—Doxorubicin—lung cancer	1.61e-05	0.000328	CcSEcCtD
Idarubicin—Decreased appetite—Paclitaxel—lung cancer	1.61e-05	0.000327	CcSEcCtD
Idarubicin—Haemoglobin—Methotrexate—lung cancer	1.6e-05	0.000326	CcSEcCtD
Idarubicin—Haemorrhage—Methotrexate—lung cancer	1.59e-05	0.000324	CcSEcCtD
Idarubicin—TOP2A—Epirubicin—Doxorubicin—lung cancer	1.58e-05	0.0152	CbGdCrCtD
Idarubicin—TOP2A—Daunorubicin—Doxorubicin—lung cancer	1.58e-05	0.0152	CbGdCrCtD
Idarubicin—Urinary tract disorder—Methotrexate—lung cancer	1.57e-05	0.00032	CcSEcCtD
Idarubicin—Anaphylactic shock—Docetaxel—lung cancer	1.57e-05	0.000319	CcSEcCtD
Idarubicin—Urethral disorder—Methotrexate—lung cancer	1.56e-05	0.000318	CcSEcCtD
Idarubicin—Infection—Docetaxel—lung cancer	1.56e-05	0.000317	CcSEcCtD
Idarubicin—Diarrhoea—Irinotecan—lung cancer	1.55e-05	0.000316	CcSEcCtD
Idarubicin—Gastrointestinal pain—Etoposide—lung cancer	1.54e-05	0.000314	CcSEcCtD
Idarubicin—Shock—Docetaxel—lung cancer	1.54e-05	0.000314	CcSEcCtD
Idarubicin—Thrombocytopenia—Docetaxel—lung cancer	1.54e-05	0.000313	CcSEcCtD
Idarubicin—Skin disorder—Docetaxel—lung cancer	1.52e-05	0.00031	CcSEcCtD
Idarubicin—Hypersensitivity—Cisplatin—lung cancer	1.52e-05	0.000309	CcSEcCtD
Idarubicin—Gastrointestinal pain—Paclitaxel—lung cancer	1.51e-05	0.000308	CcSEcCtD
Idarubicin—Diarrhoea—Gemcitabine—lung cancer	1.51e-05	0.000308	CcSEcCtD
Idarubicin—Urticaria—Etoposide—lung cancer	1.5e-05	0.000305	CcSEcCtD
Idarubicin—Stomatitis—Doxorubicin—lung cancer	1.5e-05	0.000305	CcSEcCtD
Idarubicin—Anorexia—Docetaxel—lung cancer	1.49e-05	0.000304	CcSEcCtD
Idarubicin—Abdominal pain—Etoposide—lung cancer	1.49e-05	0.000304	CcSEcCtD
Idarubicin—Body temperature increased—Etoposide—lung cancer	1.49e-05	0.000304	CcSEcCtD
Idarubicin—Urticaria—Paclitaxel—lung cancer	1.47e-05	0.000299	CcSEcCtD
Idarubicin—Abdominal pain—Paclitaxel—lung cancer	1.46e-05	0.000298	CcSEcCtD
Idarubicin—Body temperature increased—Paclitaxel—lung cancer	1.46e-05	0.000298	CcSEcCtD
Idarubicin—Angiopathy—Methotrexate—lung cancer	1.44e-05	0.000294	CcSEcCtD
Idarubicin—Vomiting—Irinotecan—lung cancer	1.44e-05	0.000294	CcSEcCtD
Idarubicin—Immune system disorder—Methotrexate—lung cancer	1.44e-05	0.000293	CcSEcCtD
Idarubicin—Rash—Irinotecan—lung cancer	1.43e-05	0.000291	CcSEcCtD
Idarubicin—Dermatitis—Irinotecan—lung cancer	1.43e-05	0.000291	CcSEcCtD
Idarubicin—Chills—Methotrexate—lung cancer	1.43e-05	0.000291	CcSEcCtD
Idarubicin—Headache—Irinotecan—lung cancer	1.42e-05	0.000289	CcSEcCtD
Idarubicin—Diarrhoea—Cisplatin—lung cancer	1.41e-05	0.000287	CcSEcCtD
Idarubicin—Alopecia—Methotrexate—lung cancer	1.41e-05	0.000286	CcSEcCtD
Idarubicin—Vomiting—Gemcitabine—lung cancer	1.41e-05	0.000286	CcSEcCtD
Idarubicin—Rash—Gemcitabine—lung cancer	1.39e-05	0.000284	CcSEcCtD
Idarubicin—Dermatitis—Gemcitabine—lung cancer	1.39e-05	0.000283	CcSEcCtD
Idarubicin—Hypersensitivity—Etoposide—lung cancer	1.39e-05	0.000283	CcSEcCtD
Idarubicin—Malnutrition—Methotrexate—lung cancer	1.39e-05	0.000282	CcSEcCtD
Idarubicin—Haemoglobin—Doxorubicin—lung cancer	1.38e-05	0.000282	CcSEcCtD
Idarubicin—Headache—Gemcitabine—lung cancer	1.38e-05	0.000282	CcSEcCtD
Idarubicin—Haemorrhage—Doxorubicin—lung cancer	1.38e-05	0.00028	CcSEcCtD
Idarubicin—Decreased appetite—Docetaxel—lung cancer	1.36e-05	0.000278	CcSEcCtD
Idarubicin—Hypersensitivity—Paclitaxel—lung cancer	1.36e-05	0.000278	CcSEcCtD
Idarubicin—Urinary tract disorder—Doxorubicin—lung cancer	1.36e-05	0.000277	CcSEcCtD
Idarubicin—Urethral disorder—Doxorubicin—lung cancer	1.35e-05	0.000275	CcSEcCtD
Idarubicin—Nausea—Irinotecan—lung cancer	1.35e-05	0.000274	CcSEcCtD
Idarubicin—TOP2A—Azacitidine—Gemcitabine—lung cancer	1.32e-05	0.0127	CbGdCrCtD
Idarubicin—Nausea—Gemcitabine—lung cancer	1.31e-05	0.000267	CcSEcCtD
Idarubicin—Vomiting—Cisplatin—lung cancer	1.31e-05	0.000267	CcSEcCtD
Idarubicin—Rash—Cisplatin—lung cancer	1.3e-05	0.000264	CcSEcCtD
Idarubicin—Dermatitis—Cisplatin—lung cancer	1.3e-05	0.000264	CcSEcCtD
Idarubicin—Diarrhoea—Etoposide—lung cancer	1.29e-05	0.000263	CcSEcCtD
Idarubicin—Gastrointestinal pain—Docetaxel—lung cancer	1.28e-05	0.000261	CcSEcCtD
Idarubicin—Anaemia—Methotrexate—lung cancer	1.28e-05	0.000261	CcSEcCtD
Idarubicin—Flushing—Doxorubicin—lung cancer	1.28e-05	0.00026	CcSEcCtD
Idarubicin—Diarrhoea—Paclitaxel—lung cancer	1.27e-05	0.000258	CcSEcCtD
Idarubicin—Angiopathy—Doxorubicin—lung cancer	1.25e-05	0.000254	CcSEcCtD
Idarubicin—Immune system disorder—Doxorubicin—lung cancer	1.24e-05	0.000253	CcSEcCtD
Idarubicin—Abdominal pain—Docetaxel—lung cancer	1.24e-05	0.000252	CcSEcCtD
Idarubicin—Body temperature increased—Docetaxel—lung cancer	1.24e-05	0.000252	CcSEcCtD
Idarubicin—Leukopenia—Methotrexate—lung cancer	1.24e-05	0.000252	CcSEcCtD
Idarubicin—Chills—Doxorubicin—lung cancer	1.24e-05	0.000252	CcSEcCtD
Idarubicin—Arrhythmia—Doxorubicin—lung cancer	1.23e-05	0.000251	CcSEcCtD
Idarubicin—Nausea—Cisplatin—lung cancer	1.22e-05	0.000249	CcSEcCtD
Idarubicin—Alopecia—Doxorubicin—lung cancer	1.22e-05	0.000248	CcSEcCtD
Idarubicin—Convulsion—Methotrexate—lung cancer	1.2e-05	0.000244	CcSEcCtD
Idarubicin—Vomiting—Etoposide—lung cancer	1.2e-05	0.000244	CcSEcCtD
Idarubicin—Malnutrition—Doxorubicin—lung cancer	1.2e-05	0.000244	CcSEcCtD
Idarubicin—Rash—Etoposide—lung cancer	1.19e-05	0.000242	CcSEcCtD
Idarubicin—Dermatitis—Etoposide—lung cancer	1.19e-05	0.000242	CcSEcCtD
Idarubicin—Headache—Etoposide—lung cancer	1.18e-05	0.000241	CcSEcCtD
Idarubicin—Chest pain—Methotrexate—lung cancer	1.18e-05	0.00024	CcSEcCtD
Idarubicin—Vomiting—Paclitaxel—lung cancer	1.18e-05	0.00024	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	1.17e-05	0.000238	CcSEcCtD
Idarubicin—Rash—Paclitaxel—lung cancer	1.17e-05	0.000238	CcSEcCtD
Idarubicin—Dermatitis—Paclitaxel—lung cancer	1.17e-05	0.000237	CcSEcCtD
Idarubicin—Headache—Paclitaxel—lung cancer	1.16e-05	0.000236	CcSEcCtD
Idarubicin—Hypersensitivity—Docetaxel—lung cancer	1.16e-05	0.000235	CcSEcCtD
Idarubicin—Anaphylactic shock—Methotrexate—lung cancer	1.13e-05	0.00023	CcSEcCtD
Idarubicin—Infection—Methotrexate—lung cancer	1.12e-05	0.000229	CcSEcCtD
Idarubicin—Nausea—Etoposide—lung cancer	1.12e-05	0.000228	CcSEcCtD
Idarubicin—Anaemia—Doxorubicin—lung cancer	1.11e-05	0.000226	CcSEcCtD
Idarubicin—Thrombocytopenia—Methotrexate—lung cancer	1.11e-05	0.000225	CcSEcCtD
Idarubicin—Nausea—Paclitaxel—lung cancer	1.1e-05	0.000224	CcSEcCtD
Idarubicin—Skin disorder—Methotrexate—lung cancer	1.1e-05	0.000224	CcSEcCtD
Idarubicin—Anorexia—Methotrexate—lung cancer	1.08e-05	0.000219	CcSEcCtD
Idarubicin—Leukopenia—Doxorubicin—lung cancer	1.07e-05	0.000219	CcSEcCtD
Idarubicin—Diarrhoea—Docetaxel—lung cancer	1.07e-05	0.000218	CcSEcCtD
Idarubicin—Convulsion—Doxorubicin—lung cancer	1.04e-05	0.000212	CcSEcCtD
Idarubicin—Chest pain—Doxorubicin—lung cancer	1.02e-05	0.000208	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	1.01e-05	0.000206	CcSEcCtD
Idarubicin—Vomiting—Docetaxel—lung cancer	9.97e-06	0.000203	CcSEcCtD
Idarubicin—Rash—Docetaxel—lung cancer	9.89e-06	0.000201	CcSEcCtD
Idarubicin—Dermatitis—Docetaxel—lung cancer	9.88e-06	0.000201	CcSEcCtD
Idarubicin—Decreased appetite—Methotrexate—lung cancer	9.83e-06	0.0002	CcSEcCtD
Idarubicin—Headache—Docetaxel—lung cancer	9.83e-06	0.0002	CcSEcCtD
Idarubicin—Anaphylactic shock—Doxorubicin—lung cancer	9.79e-06	0.000199	CcSEcCtD
Idarubicin—Infection—Doxorubicin—lung cancer	9.72e-06	0.000198	CcSEcCtD
Idarubicin—Shock—Doxorubicin—lung cancer	9.63e-06	0.000196	CcSEcCtD
Idarubicin—Thrombocytopenia—Doxorubicin—lung cancer	9.58e-06	0.000195	CcSEcCtD
Idarubicin—Skin disorder—Doxorubicin—lung cancer	9.51e-06	0.000194	CcSEcCtD
Idarubicin—Anorexia—Doxorubicin—lung cancer	9.33e-06	0.00019	CcSEcCtD
Idarubicin—Nausea—Docetaxel—lung cancer	9.32e-06	0.00019	CcSEcCtD
Idarubicin—Gastrointestinal pain—Methotrexate—lung cancer	9.24e-06	0.000188	CcSEcCtD
Idarubicin—Urticaria—Methotrexate—lung cancer	8.98e-06	0.000183	CcSEcCtD
Idarubicin—Abdominal pain—Methotrexate—lung cancer	8.94e-06	0.000182	CcSEcCtD
Idarubicin—Body temperature increased—Methotrexate—lung cancer	8.94e-06	0.000182	CcSEcCtD
Idarubicin—Decreased appetite—Doxorubicin—lung cancer	8.51e-06	0.000173	CcSEcCtD
Idarubicin—Hypersensitivity—Methotrexate—lung cancer	8.33e-06	0.00017	CcSEcCtD
Idarubicin—Gastrointestinal pain—Doxorubicin—lung cancer	8e-06	0.000163	CcSEcCtD
Idarubicin—Urticaria—Doxorubicin—lung cancer	7.78e-06	0.000158	CcSEcCtD
Idarubicin—Abdominal pain—Doxorubicin—lung cancer	7.74e-06	0.000158	CcSEcCtD
Idarubicin—Body temperature increased—Doxorubicin—lung cancer	7.74e-06	0.000158	CcSEcCtD
Idarubicin—Diarrhoea—Methotrexate—lung cancer	7.73e-06	0.000157	CcSEcCtD
Idarubicin—Hypersensitivity—Doxorubicin—lung cancer	7.21e-06	0.000147	CcSEcCtD
Idarubicin—Vomiting—Methotrexate—lung cancer	7.19e-06	0.000146	CcSEcCtD
Idarubicin—ABCC1—Transmembrane transport of small molecules—AVP—lung cancer	7.15e-06	0.000652	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—lung cancer	7.14e-06	0.000651	CbGpPWpGaD
Idarubicin—Rash—Methotrexate—lung cancer	7.13e-06	0.000145	CcSEcCtD
Idarubicin—Dermatitis—Methotrexate—lung cancer	7.12e-06	0.000145	CcSEcCtD
Idarubicin—Headache—Methotrexate—lung cancer	7.08e-06	0.000144	CcSEcCtD
Idarubicin—ABCC1—Metabolism—B4GALT5—lung cancer	7.05e-06	0.000643	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	6.93e-06	0.000632	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—ABCB1—lung cancer	6.92e-06	0.000631	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—AZIN2—lung cancer	6.88e-06	0.000628	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—COL4A3BP—lung cancer	6.88e-06	0.000628	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GSTA4—lung cancer	6.86e-06	0.000625	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—COL4A3BP—lung cancer	6.82e-06	0.000622	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—AZIN2—lung cancer	6.82e-06	0.000622	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NPPA—lung cancer	6.78e-06	0.000619	CbGpPWpGaD
Idarubicin—Nausea—Methotrexate—lung cancer	6.71e-06	0.000137	CcSEcCtD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	6.7e-06	0.000611	CbGpPWpGaD
Idarubicin—Diarrhoea—Doxorubicin—lung cancer	6.7e-06	0.000136	CcSEcCtD
Idarubicin—ABCC1—Metabolism—GSTA2—lung cancer	6.68e-06	0.000609	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PPIA—lung cancer	6.62e-06	0.000604	CbGpPWpGaD
Idarubicin—ABCC1—Disease—ALDOA—lung cancer	6.57e-06	0.000599	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GSTA1—lung cancer	6.45e-06	0.000588	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDKN2A—lung cancer	6.38e-06	0.000582	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ABCC3—lung cancer	6.37e-06	0.000581	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	6.36e-06	0.00058	CbGpPWpGaD
Idarubicin—Vomiting—Doxorubicin—lung cancer	6.22e-06	0.000127	CcSEcCtD
Idarubicin—ABCC1—Disease—ADCY1—lung cancer	6.2e-06	0.000566	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—MDM2—lung cancer	6.19e-06	0.000565	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—AKR1C1—lung cancer	6.17e-06	0.000563	CbGpPWpGaD
Idarubicin—Rash—Doxorubicin—lung cancer	6.17e-06	0.000126	CcSEcCtD
Idarubicin—Dermatitis—Doxorubicin—lung cancer	6.17e-06	0.000126	CcSEcCtD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	6.16e-06	0.000562	CbGpPWpGaD
Idarubicin—Headache—Doxorubicin—lung cancer	6.13e-06	0.000125	CcSEcCtD
Idarubicin—ABCC1—Disease—ENO2—lung cancer	6.08e-06	0.000555	CbGpPWpGaD
Idarubicin—ABCC1—Disease—SMARCA4—lung cancer	6.05e-06	0.000551	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PPP2R1B—lung cancer	6.05e-06	0.000551	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CCND1—lung cancer	6.03e-06	0.00055	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—UGT1A1—lung cancer	5.99e-06	0.000547	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ATP5H—lung cancer	5.85e-06	0.000534	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDKN1A—lung cancer	5.83e-06	0.000532	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—POMC—lung cancer	5.83e-06	0.000532	CbGpPWpGaD
Idarubicin—Nausea—Doxorubicin—lung cancer	5.81e-06	0.000118	CcSEcCtD
Idarubicin—CYP2C9—Metabolism—ATP5H—lung cancer	5.8e-06	0.000529	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—POMC—lung cancer	5.78e-06	0.000527	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GNG11—lung cancer	5.78e-06	0.000527	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	5.75e-06	0.000524	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—EP300—lung cancer	5.55e-06	0.000506	CbGpPWpGaD
Idarubicin—ABCC1—Disease—ENO1—lung cancer	5.53e-06	0.000504	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ALDOA—lung cancer	5.5e-06	0.000502	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—APOA1—lung cancer	5.47e-06	0.000499	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CCND1—lung cancer	5.39e-06	0.000492	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—NCOA3—lung cancer	5.34e-06	0.000487	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	5.33e-06	0.000486	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	5.25e-06	0.000479	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDKN1A—lung cancer	5.22e-06	0.000476	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PLBD1—lung cancer	5.22e-06	0.000476	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ADCY1—lung cancer	5.2e-06	0.000474	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ABCG2—lung cancer	5.2e-06	0.000474	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PLBD1—lung cancer	5.17e-06	0.000472	CbGpPWpGaD
Idarubicin—ABCC1—Disease—APP—lung cancer	5.14e-06	0.000469	CbGpPWpGaD
Idarubicin—ABCC1—Disease—FGF9—lung cancer	5.1e-06	0.000465	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ENO2—lung cancer	5.1e-06	0.000465	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—HPGDS—lung cancer	5.1e-06	0.000465	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	5.09e-06	0.000464	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PPP2R1B—lung cancer	5.06e-06	0.000462	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—POMC—lung cancer	5e-06	0.000456	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—MAPK3—lung cancer	4.97e-06	0.000454	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—EP300—lung cancer	4.96e-06	0.000453	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GSTT1—lung cancer	4.94e-06	0.000451	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GCLC—lung cancer	4.89e-06	0.000446	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP2A6—lung cancer	4.89e-06	0.000446	CbGpPWpGaD
Idarubicin—ABCC1—Disease—JUNB—lung cancer	4.87e-06	0.000444	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	4.87e-06	0.000444	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—MYC—lung cancer	4.84e-06	0.000441	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HSD17B10—lung cancer	4.77e-06	0.000435	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HSD17B10—lung cancer	4.73e-06	0.000431	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ENO1—lung cancer	4.63e-06	0.000422	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—CREBBP—lung cancer	4.63e-06	0.000422	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.61e-06	0.000421	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—lung cancer	4.55e-06	0.000415	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—MAPK3—lung cancer	4.45e-06	0.000406	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CKB—lung cancer	4.43e-06	0.000404	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CKB—lung cancer	4.4e-06	0.000401	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—ALB—lung cancer	4.33e-06	0.000395	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—MYC—lung cancer	4.33e-06	0.000394	CbGpPWpGaD
Idarubicin—ABCC1—Disease—FOXO3—lung cancer	4.27e-06	0.000389	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTM2—lung cancer	4.17e-06	0.00038	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CNDP2—lung cancer	4.17e-06	0.00038	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP2E1—lung cancer	4.15e-06	0.000379	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTM2—lung cancer	4.13e-06	0.000377	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CNDP2—lung cancer	4.13e-06	0.000377	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—NQO1—lung cancer	4.11e-06	0.000375	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—MTMR3—lung cancer	4.06e-06	0.00037	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.02e-06	0.000367	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—MTMR3—lung cancer	4.02e-06	0.000367	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.99e-06	0.000363	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PGAM1—lung cancer	3.95e-06	0.00036	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PGAM1—lung cancer	3.92e-06	0.000357	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—RAF1—lung cancer	3.92e-06	0.000357	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HES1—lung cancer	3.78e-06	0.000345	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP2A7—lung cancer	3.77e-06	0.000344	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP2A7—lung cancer	3.74e-06	0.000341	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—STK11—lung cancer	3.7e-06	0.000338	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SDC4—lung cancer	3.69e-06	0.000337	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SDC4—lung cancer	3.66e-06	0.000334	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—TP53—lung cancer	3.55e-06	0.000324	CbGpPWpGaD
Idarubicin—ABCC1—Disease—ERCC2—lung cancer	3.53e-06	0.000322	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.48e-06	0.000317	CbGpPWpGaD
Idarubicin—ABCC1—Disease—ERBB3—lung cancer	3.46e-06	0.000315	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GSTP1—lung cancer	3.43e-06	0.000312	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—RRM1—lung cancer	3.36e-06	0.000306	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTA3—lung cancer	3.36e-06	0.000306	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CAT—lung cancer	3.33e-06	0.000304	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—RRM1—lung cancer	3.33e-06	0.000304	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTA3—lung cancer	3.33e-06	0.000304	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.31e-06	0.000302	CbGpPWpGaD
Idarubicin—ABCC1—Disease—TERT—lung cancer	3.31e-06	0.000302	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ABCB1—lung cancer	3.24e-06	0.000296	CbGpPWpGaD
Idarubicin—ABCC1—Disease—FGFR1—lung cancer	3.22e-06	0.000293	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—TYMS—lung cancer	3.18e-06	0.00029	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HIF1A—lung cancer	3.17e-06	0.000289	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—B4GALT5—lung cancer	3.16e-06	0.000288	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GSTM1—lung cancer	3.15e-06	0.000287	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—B4GALT5—lung cancer	3.13e-06	0.000286	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTA4—lung cancer	3.07e-06	0.00028	CbGpPWpGaD
Idarubicin—ABCC1—Disease—APOA1—lung cancer	3.06e-06	0.000279	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTA4—lung cancer	3.05e-06	0.000278	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTA2—lung cancer	3e-06	0.000273	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP1A1—lung cancer	2.98e-06	0.000272	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.98e-06	0.000272	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTA2—lung cancer	2.97e-06	0.000271	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ERCC2—lung cancer	2.96e-06	0.00027	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTA1—lung cancer	2.89e-06	0.000264	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTA1—lung cancer	2.86e-06	0.000261	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ABCC3—lung cancer	2.86e-06	0.000261	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ABCC3—lung cancer	2.83e-06	0.000258	CbGpPWpGaD
Idarubicin—ABCC1—Disease—KIT—lung cancer	2.79e-06	0.000255	CbGpPWpGaD
Idarubicin—ABCC1—Disease—APC—lung cancer	2.79e-06	0.000255	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—AKR1C1—lung cancer	2.77e-06	0.000252	CbGpPWpGaD
Idarubicin—ABCC1—Disease—EGF—lung cancer	2.76e-06	0.000252	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—AKR1C1—lung cancer	2.74e-06	0.00025	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—UGT1A1—lung cancer	2.69e-06	0.000245	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—UGT1A1—lung cancer	2.66e-06	0.000243	CbGpPWpGaD
Idarubicin—ABCC1—Disease—BRAF—lung cancer	2.62e-06	0.000239	CbGpPWpGaD
Idarubicin—ABCC1—Disease—IL6R—lung cancer	2.59e-06	0.000236	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GNG11—lung cancer	2.59e-06	0.000236	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CREBBP—lung cancer	2.59e-06	0.000236	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GNG11—lung cancer	2.57e-06	0.000234	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—APOA1—lung cancer	2.56e-06	0.000234	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.56e-06	0.000233	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MAP2K1—lung cancer	2.47e-06	0.000225	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ALDOA—lung cancer	2.47e-06	0.000225	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PIK3CD—lung cancer	2.45e-06	0.000224	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.45e-06	0.000224	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ALDOA—lung cancer	2.45e-06	0.000223	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NCOA3—lung cancer	2.39e-06	0.000218	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NCOA3—lung cancer	2.37e-06	0.000217	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3CG—lung cancer	2.34e-06	0.000213	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.33e-06	0.000213	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ADCY1—lung cancer	2.33e-06	0.000212	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ABCG2—lung cancer	2.33e-06	0.000212	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ABCG2—lung cancer	2.31e-06	0.000211	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ADCY1—lung cancer	2.31e-06	0.000211	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ENO2—lung cancer	2.28e-06	0.000208	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HPGDS—lung cancer	2.28e-06	0.000208	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PPP2R1B—lung cancer	2.27e-06	0.000207	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ENO2—lung cancer	2.26e-06	0.000207	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HPGDS—lung cancer	2.26e-06	0.000207	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PPP2R1B—lung cancer	2.25e-06	0.000205	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—POMC—lung cancer	2.23e-06	0.000203	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.22e-06	0.000203	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTT1—lung cancer	2.22e-06	0.000202	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MDM2—lung cancer	2.2e-06	0.0002	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTT1—lung cancer	2.2e-06	0.0002	CbGpPWpGaD
Idarubicin—ABCC1—Disease—RAF1—lung cancer	2.19e-06	0.0002	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP2A6—lung cancer	2.19e-06	0.0002	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GCLC—lung cancer	2.19e-06	0.0002	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GCLC—lung cancer	2.17e-06	0.000198	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP2A6—lung cancer	2.17e-06	0.000198	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CREBBP—lung cancer	2.17e-06	0.000198	CbGpPWpGaD
Idarubicin—ABCC1—Disease—ERBB2—lung cancer	2.17e-06	0.000198	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.16e-06	0.000197	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MTOR—lung cancer	2.14e-06	0.000195	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PIK3CB—lung cancer	2.14e-06	0.000195	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CD4—lung cancer	2.13e-06	0.000195	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PTGS2—lung cancer	2.12e-06	0.000193	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ENO1—lung cancer	2.08e-06	0.000189	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ENO1—lung cancer	2.06e-06	0.000188	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3CD—lung cancer	2.05e-06	0.000187	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.05e-06	0.000187	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ALB—lung cancer	2.03e-06	0.000185	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.02e-06	0.000185	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP2E1—lung cancer	1.86e-06	0.00017	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CDKN1A—lung cancer	1.85e-06	0.000169	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PTEN—lung cancer	1.85e-06	0.000169	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP2E1—lung cancer	1.85e-06	0.000168	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NQO1—lung cancer	1.84e-06	0.000168	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NQO1—lung cancer	1.83e-06	0.000166	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3CB—lung cancer	1.79e-06	0.000163	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.79e-06	0.000163	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PTGS2—lung cancer	1.77e-06	0.000162	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.77e-06	0.000162	CbGpPWpGaD
Idarubicin—ABCC1—Disease—EP300—lung cancer	1.76e-06	0.000161	CbGpPWpGaD
Idarubicin—ABCC1—Disease—SRC—lung cancer	1.71e-06	0.000156	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—STK11—lung cancer	1.66e-06	0.000151	CbGpPWpGaD
Idarubicin—ABCC1—Disease—STAT3—lung cancer	1.65e-06	0.000151	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NRAS—lung cancer	1.65e-06	0.00015	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—STK11—lung cancer	1.65e-06	0.00015	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MAPK3—lung cancer	1.58e-06	0.000144	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PTEN—lung cancer	1.55e-06	0.000141	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.54e-06	0.000141	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MYC—lung cancer	1.54e-06	0.00014	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTP1—lung cancer	1.54e-06	0.00014	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTP1—lung cancer	1.52e-06	0.000139	CbGpPWpGaD
Idarubicin—ABCC1—Disease—EGFR—lung cancer	1.5e-06	0.000137	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CAT—lung cancer	1.49e-06	0.000136	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CAT—lung cancer	1.48e-06	0.000135	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—EP300—lung cancer	1.48e-06	0.000135	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.47e-06	0.000134	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ABCB1—lung cancer	1.45e-06	0.000133	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ABCB1—lung cancer	1.44e-06	0.000131	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—TYMS—lung cancer	1.43e-06	0.00013	CbGpPWpGaD
Idarubicin—ABCC1—Disease—KRAS—lung cancer	1.42e-06	0.000129	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—TYMS—lung cancer	1.42e-06	0.000129	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTM1—lung cancer	1.41e-06	0.000129	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTM1—lung cancer	1.4e-06	0.000128	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP1A1—lung cancer	1.34e-06	0.000122	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ERCC2—lung cancer	1.33e-06	0.000121	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP1A1—lung cancer	1.33e-06	0.000121	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ERCC2—lung cancer	1.32e-06	0.00012	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PIK3CA—lung cancer	1.3e-06	0.000119	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HRAS—lung cancer	1.21e-06	0.00011	CbGpPWpGaD
Idarubicin—ABCC1—Disease—IL6—lung cancer	1.15e-06	0.000105	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—APOA1—lung cancer	1.15e-06	0.000105	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—APOA1—lung cancer	1.14e-06	0.000104	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3CA—lung cancer	1.09e-06	9.96e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.09e-06	9.94e-05	CbGpPWpGaD
Idarubicin—ABCC1—Disease—AKT1—lung cancer	1.07e-06	9.71e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3CG—lung cancer	1.05e-06	9.56e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3CG—lung cancer	1.04e-06	9.47e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—POMC—lung cancer	9.97e-07	9.1e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—POMC—lung cancer	9.89e-07	9.02e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CREBBP—lung cancer	9.72e-07	8.86e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CREBBP—lung cancer	9.63e-07	8.78e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3CD—lung cancer	9.21e-07	8.4e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3CD—lung cancer	9.13e-07	8.33e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ALB—lung cancer	9.09e-07	8.29e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ALB—lung cancer	9.02e-07	8.22e-05	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—AKT1—lung cancer	8.92e-07	8.14e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3CB—lung cancer	8.03e-07	7.32e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3CB—lung cancer	7.96e-07	7.26e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PTGS2—lung cancer	7.96e-07	7.26e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PTGS2—lung cancer	7.89e-07	7.19e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PTEN—lung cancer	6.94e-07	6.33e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PTEN—lung cancer	6.88e-07	6.27e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—EP300—lung cancer	6.62e-07	6.04e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—EP300—lung cancer	6.56e-07	5.98e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3CA—lung cancer	4.89e-07	4.46e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3CA—lung cancer	4.85e-07	4.43e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—AKT1—lung cancer	4e-07	3.65e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—AKT1—lung cancer	3.96e-07	3.62e-05	CbGpPWpGaD
